Skip to content

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Abbott logo
AbbottABT
12.4%-18.4pp
ICU Medical logo
ICU MedicalICUI
-0.4%-0.2pp

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's return on equity?
iRhythm Holdings, Inc. (IRTC) reported return on equity of -53.1% in Q3 2025.
How has iRhythm Holdings, Inc. 's return on equity changed year-over-year?
iRhythm Holdings, Inc. 's return on equity increased by 48.6% year-over-year, from -103.3% to -53.1%.
What is the long-term trend for iRhythm Holdings, Inc. 's return on equity?
Over 4 years (2020 to 2024), iRhythm Holdings, Inc. 's return on equity has grown at a 42.3% compound annual growth rate (CAGR), from -18.4% to -75.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.